Pharma channel feed – Endpoints News

Pharma channel feed

Iovance stock plummets after lowered full-year guidance, missed analyst expectations for Amtagvi

Yesterday

Lonza says its US-based sites are in high demand as pharma tariffs near

Yesterday

Illumina confirms SEC has closed investigation into $8B Grail deal

2 days ago

Takeda announces handful of pipeline cuts in effort to ‘pivot resources’

2 days ago

Illumina forecasts $85M in tariff costs, decrease in China sales

2 days ago

AstraZeneca loses appeals court fight over IRA drug price negotiations

2 days ago

GSK awaits Nucala decision after FDA target date passes

2 days ago

FDA grants Verastem first approval for rare ovarian cancer treatment

2 days ago

FDA will convene vaccine advisors to discuss Covid strain updates

3 days ago

Gilead reveals plans to put another $11B into US manufacturing

3 days ago

Teva plans staff cuts as it commits to accelerating growth

3 days ago

PhRMA says tariffs are 'not the answer' as industry trade probe closes for comments

3 days ago

FDA's ODAC will review drugs for four different cancers at meeting in May

3 days ago

Avadel can pursue label expansion for narcolepsy drug Lumryz after court ruling

3 days ago

From deal to disaster: Drugmakers face a changed Washington as Trump embraces ‘most favored nation’ prices

3 days ago

Compounders just lost their case to put obesity drug tirzepatide back in shortage

3 days ago

What Vinay Prasad means for CBER, vaccines, drug approvals and more

4 days ago

Novo Nordisk trims growth forecast as GLP-1 compounder ban yet to go live

4 days ago

Sarepta’s stock plummets after Prasad appointment, low Elevidys sales

4 days ago

States sue US over plan for reorganization of federal health agencies

4 days ago

Trump, Congress look at matching some US drug prices to costs abroad

4 days ago

Trump, FDA zero in on foreign factories to give domestic sites an edge

4 days ago

Europe pledges €500M to attract global science talent

4 days ago

Vertex touts promising first few months of launch for non-opioid pain drug Journavx

5 days ago

12 3 4 Next page Last page